-transparent.png){kind=logo}
We have studied the biliary excretion of [14C] omeprazole in humans. The study was performed in eight healthy subjects and the technique used was based on multiple marker dilution principles with double-lumen tubes placed in both the stomach and intestine. The results obtained show a 16% biliary excretion of [14C] omeprazole. These data suggest a minimal "spillover" of omeprazole from the gastric mucosa into the gastric lumen in humans. The results also agree with previous data of the fecal recovery of radiolabeled omeprazole that suggest that the fecal excretion of intravenous omeprazole in humans is entirely accounted for by biliary excretion.
Related Publications
T Lind, and
T Andersson, and
I Skånberg, and
L Olbe
January 1980,
Biopharmaceutics & drug disposition,
T Lind, and
T Andersson, and
I Skånberg, and
L Olbe
December 1993,
Antimicrobial agents and chemotherapy,
T Lind, and
T Andersson, and
I Skånberg, and
L Olbe
January 1984,
Chemotherapy,
T Lind, and
T Andersson, and
I Skånberg, and
L Olbe
May 1956,
Clinical science,
T Lind, and
T Andersson, and
I Skånberg, and
L Olbe
January 1989,
Drug metabolism and disposition: the biological fate of chemicals,
T Lind, and
T Andersson, and
I Skånberg, and
L Olbe
January 1978,
Journal of toxicology and environmental health,
T Lind, and
T Andersson, and
I Skånberg, and
L Olbe
June 1974,
The Journal of nutrition,
T Lind, and
T Andersson, and
I Skånberg, and
L Olbe
March 1980,
Xenobiotica; the fate of foreign compounds in biological systems,
T Lind, and
T Andersson, and
I Skånberg, and
L Olbe
September 1980,
Pharmacological research communications,
T Lind, and
T Andersson, and
I Skånberg, and
L Olbe
January 1987,
European journal of drug metabolism and pharmacokinetics,
